-
公开(公告)号:EP3865138A1
公开(公告)日:2021-08-18
申请号:EP19870358.9
申请日:2019-09-05
发明人: SHIRAI, Takeshi , YOSHIDA, Jumpei
IPC分类号: A61K31/716 , A23K10/16 , A23K20/163 , A23K50/80 , A23L33/145 , A61K31/215 , A61K31/683 , A61K36/064 , A61P31/00 , A61P37/04
摘要: Provided is an immunostimulator containing glucan and having an immunostimulatory effect. This immunostimulator contains glucan and lipid derived from yeast cell wall and is water-insoluble. A total content percentage of glucan and lipid is 80 mass% or more, and a content ratio of lipid to glucan is 0.1 or more and 0.4 or less.
-
公开(公告)号:EP3275456B1
公开(公告)日:2021-06-02
申请号:EP16767756.6
申请日:2016-03-22
发明人: YAN, Xijun , WU, Naifeng , SUN, He , YAN, Kaijing , ZHU, Yonghong , MA, Xiaohui , ZHANG, Shunnan , LI, Changwen , BAI, Xiaolin , LI, Ting , LI, Lei , HE, Yi
IPC分类号: A61K36/82 , A61K31/357 , A61K31/355 , A61K31/683 , A61K47/24 , A61K9/28 , A61K9/48 , A61K9/66 , A61P1/16 , A61K31/205
-
公开(公告)号:EP2934505B1
公开(公告)日:2021-05-19
申请号:EP13867433.8
申请日:2013-12-18
IPC分类号: A61K31/202 , A61P9/00 , A61P25/00 , A61K36/05 , A61K31/555 , A61K31/232 , A61K31/683 , A61K31/7032 , A61K31/20 , A61K31/201 , A61K31/685 , A61K45/06 , A23D9/013 , C11B1/10 , C11B3/00 , C11B7/00
-
公开(公告)号:EP3578563B1
公开(公告)日:2021-04-14
申请号:EP19173147.0
申请日:2012-12-21
IPC分类号: C07F9/6561 , A61K31/675 , A61K31/683 , A61K31/685 , A61K31/688 , A61P35/00 , A61P35/02 , A61P35/04
-
公开(公告)号:EP3786170A1
公开(公告)日:2021-03-03
申请号:EP19794041.4
申请日:2019-04-18
发明人: FUJINO, Takehiko , MAWATARI, Shiro , YAMASHITA, Toyoharu , KITAMURA, Mitsuru , OKAUCHI, Tatsuo , HOSSAIN, Shamim
IPC分类号: C07F9/10 , C07F9/09 , A61K31/683 , A61K31/685 , A61P3/00 , A61P3/10 , A61P9/10 , A61P25/00 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61P31/00 , A61P37/02
摘要: A compound presented by the general formula (1), its racemic form, or their salt thereof (in general formula (1), X represents an oxygen atom, nitrogen atom, sulfur atom, or carbon atom, R 1 represents R 1a -Y-R 1b (wherein R 1a and R 1b independently represent a saturated or unsaturated aliphatic hydrocarbon group, aromatic group, heterocyclic group, or a combination thereof, and Y represents an oxygen atom, nitrogen atom, sulfur atom, or carbon atom), R 2 independently represents a saturated or unsaturated aliphatic hydrocarbon group, and R 3 represents choline, ethanolamine, inositol, or serine.).
-
公开(公告)号:EP3612226A1
公开(公告)日:2020-02-26
申请号:EP18725925.4
申请日:2018-04-18
申请人: Cipla Limited
发明人: MALHOTRA, Geena , JOSHI, Kalpana , RAUT, Preeti
IPC分类号: A61K45/06 , A61K31/4439 , A61K31/513 , A61K31/675 , A61K31/683 , A61P31/14 , A61P31/18
-
公开(公告)号:EP3560514A1
公开(公告)日:2019-10-30
申请号:EP17887644.7
申请日:2017-12-26
申请人: Kao Corporation
发明人: OKAHARA, Fumiaki , MORI, Takuya
IPC分类号: A61K45/00 , A61K31/16 , A61K31/404 , A61K31/519 , A61K31/683 , A61K31/685 , A61K31/717 , A61K31/718 , A61K31/722 , A61K31/734 , A61K36/73 , A61K36/899 , A61K38/00 , A61K39/395 , A61P5/00 , A61P43/00 , C07K16/26
摘要: Provided is a hypothermia preventing or ameliorating agent useful for hypothermia. The hypothermia preventing or ameliorating agent comprises a GIP function inhibitor as an active ingredient.
-
公开(公告)号:EP3550985A1
公开(公告)日:2019-10-16
申请号:EP17811314.8
申请日:2017-12-08
申请人: N.V. Nutricia
发明人: SCHIPPER, Anniek Lidewij , VAN DER BEEK, Eline Marleen , ACTON, Dennis Stanley , BARTKE, Nana , SCHOEN, Stefanie
IPC分类号: A23D9/013 , A61K31/201 , A61K31/202 , A61K31/683 , A23L33/00 , A23L33/12 , A61P25/32 , A61P25/28 , A61P25/24 , A61P25/22 , A61P25/16 , A61P25/30
-
公开(公告)号:EP2939550B1
公开(公告)日:2018-11-21
申请号:EP13868727.2
申请日:2013-12-27
申请人: Kao Corporation
发明人: ARAI, Youichi , ISHIDA, Yuki , SHIOYA, Yasushi
IPC分类号: A61K9/20 , A61K31/688 , A61K47/24 , A61K9/00 , A23L33/10 , A61K31/683
CPC分类号: A61K31/683 , A23L33/10 , A23L33/115 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K31/688 , A61K2300/00
摘要: A solid supplement comprising the following components (A) and (B): (A) sphingomyelin in an amount of from 0.15 to 7 % by mass; and (B) phosphatidyl inositol or a salt thereof, wherein the mass ratio of the content of phosphatidyl inositol or the salt thereof (B) in terms of phosphatidyl inositol content to the content of sphingomyelin (A) in the solid supplement, i.e., [(B)/(A)], is from 0.05 to 3.
-
公开(公告)号:EP3380103A1
公开(公告)日:2018-10-03
申请号:EP16815558.8
申请日:2016-11-24
申请人: Nathura S.p.A.
发明人: ALTIERI, Marianna
IPC分类号: A61K31/683 , A61K31/716 , A61K31/728 , A61K38/17 , A61K9/00 , A61K9/107 , A61K31/045 , A61P17/02 , A61P15/02
CPC分类号: A61K31/683 , A61K9/0014 , A61K9/0034 , A61K9/06 , A61K31/045 , A61K31/716 , A61K31/728 , A61K38/012 , A61K38/1767 , A61K47/10 , A61K47/44 , A61K2300/00
摘要: The present invention relates in general terms to a pharmaceutical composition for topical application, comprising an effective combination of hyaluronic acid, beta-glucan, hydrolyzed sericin, and glycerophosphoinositol or a pharmaceutically acceptable salt thereof, useful in particular as a cicatrizing agent for the treatment of micro- cracks and vulvar and/or vaginal epithelium wounds.
-
-
-
-
-
-
-
-
-